广州医药 ›› 2025, Vol. 56 ›› Issue (11): 1555-1562.DOI: 10.20223/j.cnki.1000-8535.2025.11.012

• 论著 • 上一篇    下一篇

多参数MRI在鉴别BI-RADS 4类乳腺病变良恶性中的应用

沈倩丽1, 章俊1, 薛红玉1, 李君君2, 张海青1   

  1. 1 同济大学附属东方医院庐江分院(安徽省庐江县人民医院)影像科(安徽合肥 231500)
    2 中国科学技术大学附属第一医院影像科(安徽合肥 230001)
  • 收稿日期:2025-01-24 出版日期:2025-11-20 发布日期:2025-12-25
  • 通讯作者: 张海青,E-mail:ljctzhang@163.com
  • 基金资助:
    安徽省科技计划项目(1704f0804009); 合肥市卫生健康应用医学科研项目(Hwk2024zc015; Hwk2023zc022); 中国红十字基金会2022医学赋能-领航菁英科研项目(XM_LHJY2022_05_20)

Application of multiparametric MRI in differentiating benign and malignant BI-RADS category 4 breast lesions

SHEN Qianli1, ZHANG Jun1, XUE Hongyu1, LI Junjun2, ZHANG Haiqing1   

  1. 1 Department of Imaging,Tongji University Oriental Hospital Lujiang Branch(Lujiang County People’s Hospital,Anhui Province),Hefei 231500,China
    2 Department of Imaging,the First Affiliated Hospital,University of Science and Technology of China,Hefei 230001,China
  • Received:2025-01-24 Online:2025-11-20 Published:2025-12-25

摘要: 目的 探讨多参数MRI在鉴别乳腺影像报告和数据系统(BI-RADS)4类乳腺病变良恶性中的应用。方法 回顾性分析2022年1月—2024年12月于同济大学附属东方医院庐江分院行乳腺MRI检查为BI-RADS 4类且病理结果明确肿瘤的病例268例,其中良性组166例(包括乳腺纤维腺瘤93例,导管内乳头状瘤39例,乳腺囊性增生24例,乳腺分叶状肿瘤2例,浆细胞性乳腺炎8例),恶性组102例(包括浸润性导管癌89例,浸润性小叶癌6例,黏液癌2例,炎性乳腺癌5例)。对比分析单一序列和多序列联合诊断BI-RADS 4类乳腺病变良、恶性的效能;绘制基于多参数MRI受试者工作特征(ROC)曲线,并计算曲线下面积(AUC)、特异度和灵敏度,量化多序列对于BI-RADS 4类乳腺病变良恶性的诊断效能。结果 基于多参数MRI联合诊断效能最高(AUC:0.912,95%CI:0.871~0.953),特异度为0.922,灵敏度为0.902;基于ADC值评估BI-RADS 4类乳腺病变最佳截断值为0.84×10-3 mm2/s,且均具有统计学意义(P<0.05)。结论 基于多参数MRI能够有效诊断BI-RADS 4类乳腺病变的良、恶性,为乳腺外科疾病进一步诊疗提供影像学诊断依据。

关键词: 磁共振成像, BI-RADS分类, 乳腺病变, 弥散加权成像, 动态增强

Abstract: Objective To explore the application of multiparametric MRI in differentiating benign and malignant lesions classified as BI-RADS category 4 in breast imaging.Methods A total of 268 cases of breast MRI classified as BI-RADS category 4 with confirmed tumor pathology were retrospectively analyzed from January 2022 to December 2024 at the Tongji University Oriental Hospital Lujiang Branch.Among them,166 cases were categorized as benign lesions(including 93 cases of breast fibroadenoma,39 cases of intraductal papilloma,24 cases of cystic hyperplasia,2 cases of lobular tumor,and 8 cases of plasma cell mastitis),while 102 cases were categorized as malignant lesions(including 89 cases of invasive ductal carcinoma,6 cases of invasive lobular carcinoma,2 cases of mucinous carcinoma,and 5 cases of inflammatory breast cancer).The efficacy of single-sequence versus combined multiple-sequence imaging in diagnosing benign and malignant BI-RADS category 4 breast lesions was compared and analyzed.The diagnostic efficacy of the multiparametric MRI sequences was quantified by plotting a receiver operating characteristic curve and calculating the area under the curve(AUC),as well as the specificity and sensitivity.Results The combined diagnostic efficacy of multiparametric MRI yielded the highest performance,with an AUC of 0.912(95%CI:0.871-0.953),demonstrating a specificity of 0.922 and a sensitivity of 0.902.The optimal cutoff value for differentiating BI-RADS category 4 breast lesions based on apparent diffusion coefficient values was determined to be 0.84×10-3 mm2/s,with all results being statistically significant(P<0.05).Conclusions Multiparametric MRI can effectively diagnose benign and malignant lesions classified as BI-RADS category 4,providing a reliable imaging basis for further diagnosis and treatment in breast surgery.

Key words: magnetic resonance imaging, BI-RADS category, breast lesions, diffusion weighted imaging, dynamic enhancement